Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 12 Head and Neck Neoplasms 3 Condylomata Acuminata 3 Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Exanthema 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Wounds and Injuries 1 Warts 1 Virus Diseases 1 Usual Type Vulval Intraepithelial Neoplasia (uVIN) 1 Urologic Neoplasms 1 Urologic Diseases 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Sexually Transmitted Diseases 1 Radiodermatitis 1 Parapsoriasis 1 Papillomavirus Infections 1 Non-Muscle Invasive Bladder Neoplasms 1 Non-Melanoma Skin Cancers 1 Non-Melanoma Skin Cancer (NMSC) 1 Lymphoma, Follicular 1 Keratosis, Seborrheic 1 Hypogonadism 1 Hemangioma, Cavernous 1

Interventions

Propranolol 9 Timolol 5 Prednisolone 5 Prednisone 3 Adrenergic beta-Antagonists 3 Steroids 2 Solutions 2 Saline Solution 2 Methylprednisolone 2 Adrenal Cortex Hormones 2 prednisolone phosphate 1 Vincristine 1 Urine Specimen Collection 1 Tomography, Optical Coherence 1 Therapeutics 1 Sodium Chloride 1 Sirolimus 1 Population Groups 1 Ointments 1 Observation 1 Nadolol 1 Mupirocin 1 Leuprolide 1 Lasers, Semiconductor 1 Lasers, Dye 1 Imiquimod 1 High-Energy Shock Waves 1 Hepatectomy 1 Gels 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hemangioma × Gels × Clear all

NCT02145884 2017-02-13

Topical Timolol Gel for the Treatment of Infantile Hemangiomas

Rady Children's Hospital, San Diego

Phase 2 Completed

Hemangioma, Hemangioma, Cavernous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡